Clovis Oncology to Announce Fourth Quarter/Year End 2013 Financial Results and Host Webcast Conference Call on February 27 BOULDER, Colo., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its fourth quarter/year end 2013 financial results on Thursday, February 27, 2014, after the close of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast on Thursday, February 27, at 4:30 p.m. ET to discuss the company's results in greater detail. The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com.A replay of the webcast will be available for 30 days. About Clovis Oncology Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado. CONTACT: Anna Sussman 303.625.5022 firstname.lastname@example.org Breanna Burkart 303.625.5023 email@example.com
Clovis Oncology to Announce Fourth Quarter/Year End 2013 Financial Results and Host Webcast Conference Call on February 27
Press spacebar to pause and continue. Press esc to stop.